Verified profile

Mary Sylvia

Partner at Wiley Rein, LLP

Mary Sylvia's profile photo
LocationArlingtonVirginia, United States
Current roleMember of the Board of DirectorsUmoya, Inc. · since Sep 2016
Government service1yrCourt of Appeals for the Federal Circuit

About

Mary has nearly 30 years of experience in microbiology and patent law. Trained initially as a molecular virologist, she focuses primarily on biotech and pharmaceutical patent law and the development of intellectual property strategy in both procurement and litigation settings. As a former judicial clerk to (now Senior) Circuit Judge Raymond C. Clevenger III of the U.S. Court of Appeals for the Federal Circuit, Mary combines appellate practice with patent litigation strategy. Having served as in-house counsel, as well as working in molecular biology and genetics labs prior to law school, she brings a unique perspective to her work. She understands not only the technologies with which clients work, but the ways in which an intellectual property portfolio can add value from a business development angle.

Mary currently teaches as an adjunct at Georgetown University, and formerly taught as an adjunct at the American University Washington College of Law. She also served as the first director of the University of Maryland School of Law's IP clinic.

Roles

Sep 2016–Present
Current role

Member of the Board of Directors

Umoya, Inc.

New Hampshire

Non-Profits / NGOsManagement

Umoya is a not-for-profit international wholesale carrier focused on purchasing and building Internet capacity between sovereign nations to enable low cost, high bandwidth connectivity for every person on the planet.

Feb 2014–Present
Current role

Partner

Wiley Rein LLP

Washington | Batimore, District of Columbia

Science and Technical Research and DevelopmentBiological ScienceFinancial AdvisorIntellectual Property AttorneyNatural Resources Management and Biological SciencesIntellectual Property
Nov 2013–Present
Current role

Member of the Board of Directors

Earth Sangha

Washington, District of Columbia

Director of OperationsEnvironmental, Social, and Governance (ESG)

Founded in 1997, the Earth Sangha is a nonprofit public charity based in the Washington, DC, area committed to practical environmental action as an expression of the Buddhist way of life. (“Sangha” is a Buddhist term for congregation or community.)

Jan 2011–Present
Current role

Adjunct Professor

Georgetown University

Washington, District of Columbia

ProfessorTeacher / Professor
Oct 2012–Jan 2014
Former role

Counsel

Baker & Hostetler LLP

Washington, District of Columbia

Corporate CounselLegal Officers and Practitioners
Aug 2006–Oct 2012
Former role

Counsel

Nixon Peabody, LLP

Legal Officers and Practitioners
Jan 2004–Aug 2006
Former role

Partner

Schwartz Sung & Webster, LLP

Legal Officers and Practitioners
Jan 2004–Jan 2006
Former role

Adjunct Professor

The American University Washington College of Law

Washington, District of Columbia

Teacher / Professor
Aug 2002–May 2004
Former role

Assistant Associate Professor of Law

University of Maryland School of Law

Maryland

Teacher / Professor
Jan 1999–Jan 2002
Former role

Counsel

McKenna Long & Aldridge LLPMcKenna

Legal Officers and Practitioners
Jan 1998–Jan 1999
Former role

Counsel

RIGHT

Corporate Counsel
Jan 1997–Jan 1998
Former role

IP Counsel

North American Vaccine

Corporate Counsel
Jan 1995–Jan 1997
Former role

Associate

Kirkland & Ellis LLP

Legal Officers and Practitioners
Jan 1994–Jan 1995
Former role

Law Clerk

Court of Appeals for the Federal Circuit

(appointed)District of Columbia

Law ClerkResearchLegal Assistance

Served as judicial law clerk to the Honorable Raymond C. Clevenger III, researching and drafting opinions, orders, and bench memoranda.

Jan 1991–Jan 1994
Former role

Associate

Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

Legal Officers and Practitioners

Representative matters

Experience

May 2025

Works with major pharmaceutical corporations in biologics, small molecule, and device technologies. Provides patent procurement services, freedom to operate assessments, due diligence analysis, and invalidity and non-infringement opinions. Strengthened a biologics patent portfolio, including Hatch-Waxman term extension, central to a transaction worth more than $200 million. Works with start-up companies on development of IP portfolios, including biologics, small molecules, and software technologies. Counseled drug delivery start-up through process of developing IP rights in the area: from first provisional patent to now-developed global portfolio of more than forty patents, negotiated numerous collaboration and license agreements, and ensured that client was provided with freedom to operate and acquired IP rights in order to sustain long-term security and international success. Counseled oncology and recombinant antibody client in building a biotech patent portfolio and ensured the creation and maintenance of a high-value portfolio that would protect and enhance business goals. Represents a major university in patent procurement projects involving vaccine technology. Assisted in development of strategy that allowed client to out-license technology to major vaccine developers. Assisted in many other patent procurement projects for universities and has negotiated licensing and collaboration agreements to allow technologies developed in universities to be shared with big pharma corporations and other organizations. Working with a public nonprofit charity organization to obtain trademark protection for uniquely grown and harvested coffee, and to protect the client’s distinct charity work in the area of restoration and preservation of native plant communities in northern Virginia and the Dominican Republic.

Publications & speeches

New Legal Frontiers In The Biotech Arena: Looking Beyond Myriad

The Metropolitan Corporate Counsel Vol. 22, No. 3

March 2014

Link

Mary Sylvia Discusses Federal Circuit Ruling on Roche’s Boniva Drug Patents

BioWorld Today

April 2014

Mary Sylvia, a partner in Wiley Rein’s Intellectual Property Practice, was quoted in an April 15 article published in BioWorld Today about a split decision by the U.S. Court of Appeals for the Federal Circuit that invalidated two patents owned by Hoffmann-La Roche Inc. on the grounds of obviousness.

Link

Mary Sylvia Discusses Recent Appeals Court Ruling on Stem Cells

BioWorld Today

February 2014

Mary Sylvia, a partner in Wiley Rein’s Intellectual Property Practice, was quoted in a February 7 BioWorld Today article about a recent U.S. Court of Appeals for the District of Columbia Circuit ruling on a stem cell product.

Link

Wiley Rein Bolsters Its Intellectual Property Practice with the Addition of Biotech Patent Group

Wiley.law

February 2014

Wiley Rein is pleased to announce that A. Neal Seth, Lawrence M. Sung, and Mary Sylvia have joined the firm as partners in its esteemed Intellectual Property Practice. The team—which brings a dynamic combination of scientific credentials and legal acumen—will advise clients on patent litigation strategy and appeals, patent prosecution and portfolio matters, dispute settlements, and technology transfer in the biotechnology, pharmaceutical, medical devices, and chemical industries.

Link

IP Portfolio Development For BioTech Startups In The Plant Space

Wiley.law

February 2021

Link

ASM Career Talk

American Society for Microbiology Microbe 2016 — Boston, MA

June 2016

Turning Your Science into a Company

American Society for Microbiology Graduate and Postdoctoral Opportunities — Washington, DC

October 2016